GenusPlus Group (ASX:GNP) has been awarded a contract, potentially worth $950m, to upgrade Tasmania's North West grid.

Looking back over the past 12 months, Information Technology was heads and shoulders the best-performing sector.

Mesoblast specialises in developing medicines that treat severe inflammatory conditions. Their technology is being applied to conditions like chronic heart failure and chronic low back pain.

Stocks climbed in the US on Monday as the market kicked off a holiday-shortened trading week, buoyed by strength in technology shares. The S&P 500 rose 0.73% to 5,974.07, while the Nasdaq Composite ...

Avita Medical has announced FDA approval for its new RECELL GO mini disposable cartridge. Spray-on skin The original RECELL platform received FDA approval in 2018 for severe burns ...

Simberi Gold Company, a wholly-owned subsidiary of St Barbara (ASX:SBM), has received a $210m tax assessment from Papua New Guinea’s Internal Revenue Commission.

Electro Optic Systems (ASX:EOS) has announced new orders totalling defence $33.7m. The contracts include a €8.2m ($13.6m) order for Counter-Drone Container-Based Remote Weapon Systems (CBRWS ...

Mesoblast (ASX:MSB) has received approval from the US Food and Drug Administration (FDA) for Ryoncil (remestemcel-L), making it the first mesenchymal stromal cell (MSC) therapy to be approved in ...

Austal (ASX:ASB) has been awarded a $137.02m contract to construct two additional Evolved Cape-class Patrol Boats (ECCPBs) for the Australian Border Force (ABF). This extension brings the total ...

Paladin Energy (ASX:PDN) has finalised its acquisition of Canadian uranium exploration company Fission Uranium Corp.